DOCSLIB.ORG

Gene Symbol Genbank MCF7-T MCF7-F Description

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gene Symbol Genbank MCF7-T MCF7-F Description Table S6. Altered expression of ERα signature genes in MCF7-T and MCF7-F Fold change (vs. MCF7) gene symbol genbank MCF7-T MCF7-F Description Genes positively associated with ERα expression in breast tumors A1BG NM_130786 - -3.35 Alpha-1-B glycoprotein ABAT NM_020686 -3.1 -4.55 4-aminobutyrate aminotransferase AHNAK NM_024060 -2.07 - AHNAK nucleoprotein (desmoyokin) AKR7A2 NM_003689 -1.93 -2.21 Aldo-keto reductase family 7, member A2 ALCAM NM_001627 -3.72 10.55 Activated leukocyte cell adhesion molecule ALDH6A1 NM_005589 1.67 -4.27 Aldehyde dehydrogenase 6 family, member A1 ANXA9 NM_003568 -8.4 2.11 Annexin A9 APRIN NM_015928 1.47 -2.28 Androgen-induced proliferation inhibitor ARL3 NM_004311 - -5.73 ADP-ribosylation factor-like 3 AZGP1 NM_001185 -5.62 -3.22 MRNA; cDNA DKFZp762C115 (from clone DKFZp762C115) BAG3 NM_004281 -2.52 -3.55 BCL2-associated athanogene 3 BC-2 NM_198426 - -2.52 Putative breast adenocarcinoma marker (32kD) BCAS4 NM_198799 - -2.1 Breast carcinoma amplified sequence 4 BLVRA NM_000712 - -4.08 Biliverdin reductase A BTD NM_000060 -1.77 -2.11 Biotinidase BTF3 NM_001207 - -2.75 Basic transcription factor 3 C10orf116 NM_006829 -1.84 -4.06 Chromosome 10 open reading frame 116 C14orf132 NM_020215 - -3.66 Chromosome 14 open reading frame 132 C18orf1 NM_181483 2.44 -6.83 Chromosome 18 open reading frame 1 C20orf35 NM_033542 1.27 -3.13 Chromosome 20 open reading frame 35 C21orf59 NM_021254 -1.72 -2.15 Chromosome 21 open reading frame 59 C9orf46 NM_018465 - -3.17 Chromosome 9 open reading frame 46 CAP2 NM_006366 -3.23 -6.03 CAP, adenylate cyclase-associated protein, 2 (yeast) CCND1 NM_053056 -1.91 -2.52 Cyclin D1 (PRAD1: parathyroid adenomatosis 1) CGI-111 NM_016048 1.47 -3.47 CGI-111 protein CLN3 NM_000086 -2.02 - Ceroid-lipofuscinosis, neuronal 3, juvenile COL4A3BP NM_031361 - -2.16 Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein COX6C NM_004374 - -2.31 Cytochrome c oxidase subunit VIc COX7A2 NM_001865 - -2.28 Cytochrome c oxidase subunit VIIa polypeptide 2 (liver) CREBL2 NM_001310 - -2.04 CAMP responsive element binding protein-like 2 CRI1 NM_014335 - -4.09 CREBBP/EP300 inhibitor 1 CRIP1 NM_001311 -3.7 -12.4 Cysteine-rich protein 1 (intestinal) CRIP2 NM_001312 -5.03 -5.3 Cysteine-rich protein 2 CTBP2 NM_022802 -1.22 -2.5 C-terminal binding protein 2 CTDSP1 NM_182642 - -2.12 CTD small phosphatase 1 CXXC5 NM_016463 -8.1 -1.62 CXXC finger 5 CYB5 NM_148923 -2.26 -4.37 Cytochrome b-5 DEAF1 NM_021008 - -2.38 Deformed epidermal autoregulatory factor 1 (Drosophila) DEPDC6 NM_022783 -2.71 -1.73 DEP domain containing 6 DHRS2 NM_182908 -2.77 4.17 Dehydrogenase/reductase (SDR family) member 2 DHRS4 NM_021004 - -2.33 Dehydrogenase/reductase (SDR family) member 4 DNAJC12 NM_201262 -3.42 -47.9 DnaJ (Hsp40) homolog, subfamily C, member 12 DRAP1 NM_006442 - -2.17 DR1-associated protein 1 (negative cofactor 2 alpha) DUSP4 NM_057158 -4.4 -1.47 Dual specificity phosphatase 4 ENSA NM_004436 1.6 -2.21 Endosulfine alpha ERBB4 NM_005235 - -2.6 V-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) ESR1 NM_000125 -2.19 -25.89 Estrogen receptor 1 ETNK2 NM_018208 - -2.04 Ethanolamine kinase 2 EVL NM_016337 1.68 -2.65 Enah/Vasp-like FBP1 NM_000507 -1.31 -2.82 Fructose-1,6-bisphosphatase 1 FER1L3 NM_133337 -2.88 3.03 Fer-1-like 3, myoferlin (C. elegans) FLJ10116 NM_018000 - -5.2 Whn-dependent transcript 2 FLJ20366 NM_017786 1.27 -5.37 Hypothetical protein FLJ20366 FOXA1 NM_004496 - -6.56 Forkhead box A1 GALNT10 NM_198321 -2.53 2.16 GalNAc-T10 GATA3 NM_032742 -1.41 -2.55 GATA binding protein 3 GFRA1 NM_145793 -3.45 -21.48 GDNF family receptor alpha 1 GLUL NM_002065 -2.15 - Glutamate-ammonia ligase (glutamine synthase) GPHN NM_020806 1.45 -2.65 Gephyrin Table S6. Altered expression of ERα signature genes in MCF7-T and MCF7-F (continued) Fold change (vs. MCF7) gene symbol genbank MCF7-T MCF7-F Description Genes positively associated with ERα expression in breast tumors GREB1 NM_148903 -97.81 -59.66 GREB1 protein GSTM3 NM_000849 - -8.26 Glutathione S-transferase M3 (brain) GSTZ1 NM_145871 1.61 -6.99 Glutathione transferase zeta 1 (maleylacetoacetate isomerase) HAGH NM_005326 -1.72 -2.51 Hydroxyacylglutathione hydrolase HEBP1 NM_015987 -1.62 -2.56 Heme binding protein 1 HIST1H2BD NM_138720 -1.35 -2.68 Histone 1, H2bd HOXC6 NM_153693 2.29 -2.3 Homeo box C6 HSPA2 NM_021979 3.7 -3.36 Heat shock 70kDa protein 2 HSPB1 NM_001540 -1.57 -3.02 Heat shock 27kDa protein 1 HSPB8 NM_014365 -1.86 -7.28 Heat shock 22kDa protein 8 ICA1 NM_022308 -1.94 -2.16 Islet cell autoantigen 1, 69kDa IGBP1 NM_001551 - -3.39 Immunoglobulin (CD79A) binding protein 1 IMPACT NM_018439 1.42 -2.52 Hypothetical protein IMPACT INPP4B NM_003866 -3.24 -2.96 Inositol polyphosphate-4-phosphatase, type II, 105kDa ITPK1 NM_014216 - -2.64 Inositol 1,3,4-triphosphate 5/6 kinase KIAA1143 NM_020696 - -5.14 KIAA1143 protein KIAA1181 NM_020462 -2.49 -2.6 Endoplasmic reticulum-golgi intermediate compartment 32 kDa protein KIAA1324 NM_020775 1.59 -20.11 Maba1 KIAA1443 NM_020834 - -2.08 KIAA1443 KIF3B NM_004798 -2.33 -1.46 Kinesin family member 3B KIF9 NM_182903 -1.75 -2.82 Kinesin family member 9 KRT8 NM_002273 - -2.13 Keratin 8 LRBA NM_006726 - -2.02 LPS-responsive vesicle trafficking, beach and anchor containing LRIG1 NM_015541 2.93 -2.02 Leucine-rich repeats and immunoglobulin-like domains 1 LZTFL1 NM_020347 -1.33 -2.02 Leucine zipper transcription factor-like 1 MGC2650 NM_024108 - -2.56 Hypothetical protein MGC2650 MIPEP NM_005932 -10.63 -5.42 Mitochondrial intermediate peptidase MOAP1 NM_022151 1.47 -3.15 Modulator of apoptosis 1 MPI NM_002435 - -2.24 Mannose phosphate isomerase MRPL24 NM_145729 - -4.12 Mitochondrial ribosomal protein L24 MTL5 NM_004923 -1.61 -3.07 Metallothionein-like 5, testis-specific (tesmin) MUC1 NM_182741 -3.33 -2.38 Mucin 1, transmembrane MYB NM_005375 -1.7 -2.88 V-myb myeloblastosis viral oncogene homolog (avian) MYO6 NM_004999 -2.39 2.66 myosin VI NAT1 NM_000662 -1.75 -2.85 N-acetyltransferase 1 (arylamine N-acetyltransferase) NCDN NM_014284 - -2.09 Neurochondrin NDUFA7 NM_005001 - -2.67 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa NEBL NM_006393 -1.61 -2.42 Nebulette NEDD4L NM_015277 -2.94 -3.66 Neural precursor cell expressed, developmentally down-regulated 4-like NEUGRIN NM_016645 - -2.68 Mesenchymal stem cell protein DSC92 NPY1R NM_000909 -10.26 -580.16 Neuropeptide Y receptor Y1 NUDT2 NM_147173 - -3.73 Nudix (nucleoside diphosphate linked moiety X)-type motif 2 PDZK1 NM_002614 -3.09 -15.25 PDZ domain containing 1 PECI NM_006117 - -2.19 Peroxisomal D3,D2-enoyl-CoA isomerase PEX12 NM_000286 - -2.1 Peroxisomal biogenesis factor 12 PHPT1 NM_014172 - -2.55 Phosphohistidine phosphatase 1 PLEKHA6 NM_014935 -1.7 -2.35 Pleckstrin homology domain containing, family A member 6 PLEKHF2 NM_024613 -2.21 -3.55 Pleckstrin homology domain containing, family F PLK2 NM_006622 -5.84 - Polo-like kinase 2 (Drosophila) PMVK NM_006556 - -3.6 Phosphomevalonate kinase PNMA1 NM_006029 1.54 -2.85 Paraneoplastic antigen MA1 POLB NM_002690 - -3.65 Polymerase (DNA directed), beta POLR2L NM_021128 - -6.48 Polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa PPP2R5A NM_006243 - -2.24 Protein phosphatase 2, regulatory subunit B (B56), alpha isoform PREX1 NM_020820 1.3 -40.66 Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 1 PTP4A2 NM_080392 -1.45 -2.65 Protein tyrosine phosphatase type IVA, member 2 PUNC NM_004884 -2.06 - Putative neuronal cell adhesion molecule PURA NM_005859 - -2.5 Purine-rich element binding protein A PURB NM_033224 - -3.3 Purine-rich element binding protein B Table S6. Altered expression of ERα-positive tumor signature genes in MCF7-T and MCF7-F (continued) Fold change (vs. MCF7) gene symbol genbank MCF7-T MCF7-F Description Genes positively associated with ERα expression in breast tumors QDPR NM_000320 - -2.05 Quinoid dihydropteridine reductase RAB11A NM_004663 - -2.75 RAB11A, member RAS oncogene family RAB31 NM_006868 - -5.22 RAB31, member RAS oncogene family RAB5C NM_201434 - -4.04 RAB5C, member RAS oncogene family RARA NM_000964 - -2.66 Retinoic acid receptor, alpha RRM2B NM_015713 - -2.2 Ribonucleotide reductase M2 B (TP53 inducible) SALL2 NM_005407 - -4.43 Sal-like 2 (Drosophila) SELENBP1 NM_003944 2.06 -3.81 Selenium binding protein 1 SGKL NM_170709 1.6 -4.31 Serum/glucocorticoid regulated kinase-like SH3BGRL NM_003022 -3.92 -1.4 SH3 domain binding glutamic acid-rich protein like SIAH2 NM_005067 -1.62 -3.21 Seven in absentia homolog 2 (Drosophila) SKP1A NM_170679 1.29 -2.76 S-phase kinase-associated protein 1A (p19A) SLC9A3R1 NM_004252 -1.68 -3.42 Solute carrier family 9, isoform 3 regulator 1 SLC9A5 NM_004594 - -2.07 Solute carrier family 9 (sodium/hydrogen exchanger), isoform 5 SORD NM_003104 1.44 -4.84 Sorbitol dehydrogenase SPDEF NM_012391 - -15.48 SAM pointed domain containing ets transcription factor SRP14 NM_003134 - -3.87 Signal recognition particle 14kDa STARD10 NM_006645 -2.48 -7.07 START domain containing 10 STC2 NM_003714 - -2.54 Stanniocalcin 2 SUCLG2 NM_003848 - -2.19 Succinate-CoA ligase, GDP-forming, beta subunit TCEAL4 NM_024863 - -3.04 Transcription elongation factor A (SII)-like 4 TENC1 NM_198316 - -9.67 Tensin like C1 domain containing phosphatase TFF1 NM_003225 1.26 -7.57 Trefoil factor 1 TFF3 NM_003226 -13.71 -75.86 Trefoil factor 3 (intestinal) TNNT1 NM_003283 - -8.89 Troponin T1, skeletal, slow TNRC9 XM_941030 -27.24 -6.6 trinucleotide repeat containing 9 TOB1 NM_005749 - -5.03 Transducer of ERBB2, 1 TRPS1 NM_014112 -2.08 -2.9 Trichorhinophalangeal syndrome I TUSC2 NM_007275
Load more

Recommended publications
  • The T-ALL Related Gene BCL11B Regulates the Initial Stages of Human T-Cell Differentiation
    Leukemia (2017) 31, 2503–2514 © 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 0887-6924/17 www.nature.com/leu ORIGINAL ARTICLE The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation VL Ha1, A Luong1,FLi2, D Casero3, J Malvar1,YMKim1,4, R Bhatia5, GM Crooks3,6,7,8 and C Parekh1,4 The initial stages of T-cell differentiation are characterized by a progressive commitment to the T-cell lineage, a process that involves the loss of alternative (myelo-erythroid, NK, B) lineage potentials. Aberrant differentiation during these stages can result in T-cell acute lymphoblastic leukemia (T-ALL). However, the mechanisms regulating the initial stages of human T-cell differentiation are obscure. Through loss of function studies, we showed BCL11B, a transcription factor recurrently mutated T-ALL, is essential for T-lineage commitment, particularly the repression of NK and myeloid potentials, and the induction of T-lineage genes, during the initial stages of human T-cell differentiation. In gain of function studies, BCL11B inhibited growth of and induced a T-lineage transcriptional program in T-ALL cells. We found previously unknown differentiation stage-specific DNA binding of BCL11B at multiple T-lineage genes; target genes showed BCL11B-dependent expression, suggesting a transcriptional activator role for BCL11B at these genes. Transcriptional analyses revealed differences in the regulatory actions of BCL11B between human and murine thymopoiesis. Our studies show BCL11B is a key regulator of the initial stages of human T-cell differentiation and delineate the BCL11B transcriptional program, enabling the dissection of the underpinnings of normal T-cell differentiation and providing a resource for understanding dysregulations in T-ALL.
    [Show full text]
  • Supp Material.Pdf
    Legends for Supplemental Figures and Tables Figure S1. Expression of Tlx during retinogenesis. (A) Staged embryos were stained for β- galactosidase knocked into the Tlx locus to indicate Tlx expression. Tlx was expressed in the neural blast layer in the early phase of neural retina development (blue signal). (B) Expression of Tlx in neural retina was quantified using Q-PCR at multiple developmental stages. Figure S2. Expression of p27kip1 and cyclin D1 (Ccnd1) at various developmental stages in wild-type or Tlx-/- retinas. (A) Q-PCR analysis of p27kip1 mRNA expression. (B) Western blotting analysis of p27kip1 protein expression. (C) Q-PCR analysis of cyclin D1 mRNA expression. Figure S3. Q-PCR analysis of mRNA expression of Sf1 (A), Lrh1 (B), and Atn1 (C) in wild-type mouse retinas. RNAs from testis and liver were used as controls. Table S1. List of genes dysregulated both at E15.5 and P0 Tlx-/- retinas. Gene E15.5 P0 Cluste Gene Title Fold Fold r Name p-value p-value Change Change nuclear receptor subfamily 0, group B, Nr0b1 1.65 0.0024 2.99 0.0035 member 1 1 Pou4f3 1.91 0.0162 2.39 0.0031 POU domain, class 4, transcription factor 3 1 Tcfap2d 2.18 0.0000 2.37 0.0001 transcription factor AP-2, delta 1 Zic5 1.66 0.0002 2.02 0.0218 zinc finger protein of the cerebellum 5 1 Zfpm1 1.85 0.0030 1.88 0.0025 zinc finger protein, multitype 1 1 Pten 1.60 0.0155 1.82 0.0131 phospatase and tensin homolog 2 Itgb5 -1.85 0.0063 -1.85 0.0007 integrin beta 5 2 Gpr49 6.86 0.0001 15.16 0.0001 G protein-coupled receptor 49 3 Cmkor1 2.60 0.0007 2.72 0.0013
    [Show full text]
  • C57BL/6 and 129 Inbred Mouse Strains Differ in Gbp2 and Gbp2b
    Wellcome Open Research 2019, 4:124 Last updated: 30 JAN 2020 RESEARCH ARTICLE C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo [version 1; peer review: 2 approved] Barbara Clough 1*, Ryan Finethy2*, Rabia T. Khan1*, Daniel Fisch 1*, Sarah Jordan1, Harshil Patel 3, Jörn Coers 2,4*, Eva-Maria Frickel 1* 1Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK 2Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 3Bioinformatics and Biostatistics, The Francis Crick Institute, London, NW1 1AT, UK 4Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA * Equal contributors First published: 20 Aug 2019, 4:124 ( Open Peer Review v1 https://doi.org/10.12688/wellcomeopenres.15329.1) Latest published: 20 Aug 2019, 4:124 ( https://doi.org/10.12688/wellcomeopenres.15329.1) Reviewer Status Abstract Invited Reviewers Background: Infections cause the production of inflammatory cytokines 1 2 such as Interferon gamma (IFNγ). IFNγ in turn prompts the upregulation of a range of host defence proteins including members of the family of version 1 guanylate binding proteins (Gbps). In humans and mice alike, GBPs restrict 20 Aug 2019 report report the intracellular replication of invasive microbes and promote inflammation. To study the physiological functions of Gbp family members, the most commonly chosen in vivo models are mice harbouring loss-of-function mutations in either individual Gbp genes or the entire Gbp gene cluster on 1 Peter Staeheli, University of Freiburg, Freiburg, mouse chromosome 3. Individual Gbp deletion strains differ in their design, Germany as some strains exist on a pure C57BL/6 genetic background, while other strains contain a 129-derived genetic interval encompassing the Gbp gene 2 Igor Kramnik , Boston University School of cluster on an otherwise C57BL/6 genetic background.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • An Essential Role for Maternal Control of Nodal Signaling
    RESEARCH ARTICLE elife.elifesciences.org An essential role for maternal control of Nodal signaling Pooja Kumari1,2†, Patrick C Gilligan1†, Shimin Lim1,3, Long Duc Tran4, Sylke Winkler5, Robin Philp6‡, Karuna Sampath1,2,3* 1Temasek Life Sciences Laboratory, National University of Singapore, Singapore, Singapore; 2Department of Biological Sciences, National University of Singapore, Singapore, Singapore; 3School of Biological Sciences, Nanyang Technological University, Singapore, Singapore; 4Mechanobiology Institute, National University of Singapore, Singapore, Singapore; 5Department of Cell Biology and Genetics, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany; 6Bioprocessing Technology Institute, A*STAR, Singapore, Singapore Abstract Growth factor signaling is essential for pattern formation, growth, differentiation, and maintenance of stem cell pluripotency. Nodal-related signaling factors are required for axis formation and germ layer specification from sea urchins to mammals. Maternal transcripts of the zebrafish Nodal factor, Squint (Sqt), are localized to future embryonic dorsal. The mechanisms by which maternal sqt/nodal RNA is localized and regulated have been unclear. Here, we show that maternal control of Nodal signaling via the conserved Y box-binding protein 1 (Ybx1) is essential. We identified Ybx1 via a proteomic screen. Ybx1 recognizes the 3’ untranslated region (UTR) of *For correspondence: karuna@ sqt RNA and prevents premature translation and Sqt/Nodal signaling. Maternal-effect mutations in tll.org.sg zebrafish ybx1 lead to deregulated Nodal signaling, gastrulation failure, and embryonic lethality. Implanted Nodal-coated beads phenocopy ybx1 mutant defects. Thus, Ybx1 prevents ectopic † These authors contributed Nodal activity, revealing a new paradigm in the regulation of Nodal signaling, which is likely to equally to this work be conserved.
    [Show full text]
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Human Cytomegalovirus Use and Manipulation of Host Phospholipids
    Human Cytomegalovirus Use and Manipulation of Host Phospholipids Item Type text; Electronic Thesis Authors Harwood, Samuel John Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction, presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 27/09/2021 22:10:36 Link to Item http://hdl.handle.net/10150/632563 HUMAN CYTOMEGALOVIRUS USE AND MANIPULATION OF HOST PHOSPHOLIPIDS by Samuel Harwood ____________________________ Copyright © Samuel Harwood 2019 A Thesis Submitted to the Faculty of the DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY In Partial Fulfillment of the Requirements For the Degree of MASTER OF SCIENCE In the Graduate College THE UNIVERSITY OF ARIZONA 2019 2 THE UNIVERSITY OF ARIZONA GRADUATE COLLEGE As members of the Master's Committee, we certify that we have read the thesis prepared by Samuel Harwood, titled Human Cytomegalovirus Use and Man.!.e.ulationof Host Phos holipids, and recommend that it be accepted as fulfilling the thesis requirement for the Master's Degree. Z'i Date +/ I Z.OI � . 4/ 1 / 7 Date: 2 r ( Date: � /L<I' IC, Final approval and acceptance of this thesis is contingent upon the candidate's submission of the final copies of the thesis to the Graduate College. I hereby certify that I have read this thesis prepared under my direction and recommend that it be accepted as fulfilling the Master's requirement. 4/ 1 '��v Date: 2 I 2ol � Dr.
    [Show full text]
  • The N-Cadherin Interactome in Primary Cardiomyocytes As Defined Using Quantitative Proximity Proteomics Yang Li1,*, Chelsea D
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs221606. doi:10.1242/jcs.221606 TOOLS AND RESOURCES The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics Yang Li1,*, Chelsea D. Merkel1,*, Xuemei Zeng2, Jonathon A. Heier1, Pamela S. Cantrell2, Mai Sun2, Donna B. Stolz1, Simon C. Watkins1, Nathan A. Yates1,2,3 and Adam V. Kwiatkowski1,‡ ABSTRACT requires multiple adhesion, cytoskeletal and signaling proteins, The junctional complexes that couple cardiomyocytes must transmit and mutations in these proteins can cause cardiomyopathies (Ehler, the mechanical forces of contraction while maintaining adhesive 2018). However, the molecular composition of ICD junctional homeostasis. The adherens junction (AJ) connects the actomyosin complexes remains poorly defined. – networks of neighboring cardiomyocytes and is required for proper The core of the AJ is the cadherin catenin complex (Halbleib and heart function. Yet little is known about the molecular composition of the Nelson, 2006; Ratheesh and Yap, 2012). Classical cadherins are cardiomyocyte AJ or how it is organized to function under mechanical single-pass transmembrane proteins with an extracellular domain that load. Here, we define the architecture, dynamics and proteome of mediates calcium-dependent homotypic interactions. The adhesive the cardiomyocyte AJ. Mouse neonatal cardiomyocytes assemble properties of classical cadherins are driven by the recruitment of stable AJs along intercellular contacts with organizational and cytosolic catenin proteins to the cadherin tail, with p120-catenin β structural hallmarks similar to mature contacts. We combine (CTNND1) binding to the juxta-membrane domain and -catenin β quantitative mass spectrometry with proximity labeling to identify the (CTNNB1) binding to the distal part of the tail.
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • The Histone Methyltransferase DOT1L Prevents Antigen-Independent
    bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells Eliza Mari Kwesi-Maliepaard1*, Muhammad Assad Aslam2,3*, Mir Farshid Alemdehy2*, Teun van den Brand4, Chelsea McLean1, Hanneke Vlaming1, Tibor van Welsem1, Tessy Korthout1, Cesare Lancini1, Sjoerd Hendriks1, Tomasz Ahrends5, Dieke van Dinther6, Joke M.M. den Haan6, Jannie Borst5, Elzo de Wit4, Fred van Leeuwen1,7,#, and Heinz Jacobs2,# 1Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 2Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 3Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, 60800 Multan, Pakistan 4Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 5Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 6Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, 1081HV Amsterdam, The Netherlands 7Department of Medical Biology, Amsterdam UMC, location AMC, UvA, 1105 AZ Amsterdam, The Netherlands * These authors contributed equally to this work. # Equal contribution and corresponding authors [email protected]; [email protected] Lead contact: Fred van Leeuwen 1 bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Targeting the Tryptophan Hydroxylase 2 Gene for Functional Analysis in Mice and Serotonergic Differentiation of Embryonic Stem Cells
    TARGETING THE TRYPTOPHAN HYDROXYLASE 2 GENE FOR FUNCTIONAL ANALYSIS IN MICE AND SEROTONERGIC DIFFERENTIATION OF EMBRYONIC STEM CELLS Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Dana Kikic, M.Sc. in Molecular biology and Physiology from Nis June, 2009 The doctorate studies were performed in the research group of Prof. Michael Bader Molecular Biology of Peptide Hormones at Max-Delbrück-Center for Molecular Medicine in Berlin, Buch Mai 2005 - September 2008. 1st Reviewer: Prof. Michael Bader 2nd Reviewer: Prof. Udo Heinemann date of defence: 13. August 2009 ACKNOWLEDGMENTS Herewith, I would like to acknowledge the persons who made this thesis possible and without whom my initiation in the world of basic science research would not have the spin it has now, neither would my scientific illiteracy get the chance to eradicate. I am expressing my very personal gratitude and recognition to: Prof. Michael Bader, for an inexhaustible guidance in all the matters arising during the course of scientific work, for an instinct in defining and following the intellectual challenge and for letting me following my own, for necessary financial support, for defining the borders of reasonable and unreasonable, for an invaluable time and patience, and an amazing efficiency in supporting, motivating, reading, correcting and shaping my scientific language during the last four years. Prof. Harald Saumweber and Prof. Udo Heinemann, for taking over the academic supervision of the thesis, and for breathing in it a life outside the laboratory walls and their personal signature.
    [Show full text]